Search results
Results from the WOW.Com Content Network
Dementia with Lewy bodies (DLB) is a type of dementia, a group of diseases involving progressive neurodegeneration of the central nervous system. [11] It is one of the two Lewy body dementias, along with Parkinson's disease dementia. [12] Dementia with Lewy bodies can be classified in other ways.
Dementia with Lewy bodies is the second most common type of dementia after Alzheimer’s disease, comprising between 15-20% of all dementia diagnoses. Also known as Lewy body dementia, it is ...
Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. [5] [6] [10] It appears to result in a small benefit in mental function and ability to function. [11]
Childhood dementia is very often diagnosed late, misdiagnosed, or not diagnosed at all. [9] A correct diagnosis happens, on average, 2 years or more after symptoms become apparent. Additionally, children affected by childhood dementia are often misdiagnosed with: Autism [16] [9] [17] Developmental or intellectual delay [16] [9] ADHD [9] Others [9]
Lewy body dementia symptoms. Lewy body dementia can cause various symptoms that may impact a person’s cognition, movement, sleep and behavior. According to the NIA, those can include: Hallucinations
Vitamin D influences a lot of cellular functions in the body—so it’s possible that mild deficiencies can impact the development of aging-related brain changes, says David Merrill, MD, PhD, a ...
Lewy body dementia (LBD) is an umbrella term for two similar and common subtypes of dementia: [1] dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD).
Memantine/donepezil, sold under the brand name Namzaric among others, is a fixed dose combination medication used for the treatment of dementia of the Alzheimer's type. [1] It contains memantine, as the hydrochloride, a NMDA receptor antagonist; and donepezil as the hydrochloride, an acetylcholinesterase inhibitor. [1] It is taken by mouth. [1]